Harmony Biosciences Holdings (HRMY) Non-Current Assets (2019 - 2026)

Harmony Biosciences Holdings has disclosed Non-Current Assets across 8 years of filings, most recently posting $493.0 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $493.0 million, up 19.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $493.0 million (up 19.42% YoY), and the FY2025 annual result was $364.6 million, down 13.18% from the prior year.
• Non-Current Assets came in at $493.0 million for Q1 2026 at Harmony Biosciences Holdings, up from $364.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $493.0 million in Q1 2026 to a low of $182.3 million in Q2 2022.
• The 5-year median for Non-Current Assets is $364.6 million (2025), against an average of $342.8 million.
• Across the five-year window, Non-Current Assets surged 83.61% in 2022 and slipped 13.18% in 2025, its largest moves.
• Harmony Biosciences Holdings' Non-Current Assets stood at $273.6 million in 2022, then jumped by 31.72% to $360.4 million in 2023, then climbed by 16.53% to $419.9 million in 2024, then dropped by 13.18% to $364.6 million in 2025, then soared by 35.21% to $493.0 million in 2026.
• The last three Non-Current Assets figures came in at $493.0 million (Q1 2026), $364.6 million (Q4 2025), and $369.4 million (Q3 2025), per Business Quant data.